Pulmonx Corporation Statistics
Share Statistics
Pulmonx Corporation has 39.49M shares outstanding. The number of shares has increased by 2.47% in one year.
| Shares Outstanding | 39.49M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.86% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 35.82M |
| Failed to Deliver (FTD) Shares | 227 |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 831.84K, so 2.11% of the outstanding shares have been sold short.
| Short Interest | 831.84K |
| Short % of Shares Out | 2.11% |
| Short % of Float | 2.32% |
| Short Ratio (days to cover) | 3.78 |
Valuation Ratios
The PE ratio is -7.96 and the forward PE ratio is -4.39.
| PE Ratio | -7.96 |
| Forward PE | -4.39 |
| PS Ratio | 7.05 |
| Forward PS | 2.2 |
| PB Ratio | 4.09 |
| P/FCF Ratio | -12.6 |
| PEG Ratio | n/a |
Enterprise Valuation
Pulmonx Corporation has an Enterprise Value (EV) of 441.82M.
| EV / Earnings | -7.26 |
| EV / Sales | 6.43 |
| EV / EBITDA | -8.02 |
| EV / EBIT | -7.13 |
| EV / FCF | -11.5 |
Financial Position
The company has a current ratio of 6.5, with a Debt / Equity ratio of 0.31.
| Current Ratio | 6.5 |
| Quick Ratio | 5.77 |
| Debt / Equity | 0.31 |
| Total Debt / Capitalization | 23.94 |
| Cash Flow / Debt | -1.01 |
| Interest Coverage | -19.16 |
Financial Efficiency
Return on equity (ROE) is -0.51% and return on capital (ROIC) is -39.14%.
| Return on Equity (ROE) | -0.51% |
| Return on Assets (ROA) | -0.34% |
| Return on Capital (ROIC) | -39.14% |
| Revenue Per Employee | 246.15K |
| Profits Per Employee | -218.08K |
| Employee Count | 279 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.07 |
Taxes
| Income Tax | 571.00K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -45.33% in the last 52 weeks. The beta is 0.68, so Pulmonx Corporation's price volatility has been higher than the market average.
| Beta | 0.68 |
| 52-Week Price Change | -45.33% |
| 50-Day Moving Average | 6.51 |
| 200-Day Moving Average | 7.23 |
| Relative Strength Index (RSI) | 51.87 |
| Average Volume (20 Days) | 221.63K |
Income Statement
In the last 12 months, Pulmonx Corporation had revenue of 68.67M and earned -60.84M in profits. Earnings per share was -1.6.
| Revenue | 68.67M |
| Gross Profit | 50.75M |
| Operating Income | -61.94M |
| Net Income | -60.84M |
| EBITDA | -55.09M |
| EBIT | -61.94M |
| Earnings Per Share (EPS) | -1.6 |
Balance Sheet
The company has 83.55M in cash and 41.42M in debt, giving a net cash position of 42.12M.
| Cash & Cash Equivalents | 83.55M |
| Total Debt | 41.42M |
| Net Cash | 42.12M |
| Retained Earnings | -411.16M |
| Total Assets | 167.40M |
| Working Capital | 122.63M |
Cash Flow
In the last 12 months, operating cash flow was -37.61M and capital expenditures -807.00K, giving a free cash flow of -38.42M.
| Operating Cash Flow | -37.61M |
| Capital Expenditures | -807.00K |
| Free Cash Flow | -38.42M |
| FCF Per Share | -1.01 |
Margins
Gross margin is 7.39K%, with operating and profit margins of -9.02K% and -8.86K%.
| Gross Margin | 7.39K% |
| Operating Margin | -9.02K% |
| Pretax Margin | -8.78K% |
| Profit Margin | -8.86K% |
| EBITDA Margin | -80.22% |
| EBIT Margin | -90.19% |
| FCF Margin | -55.94% |
Dividends & Yields
LUNG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -24.43% |
| FCF Yield | -14.85% |
Analyst Forecast
The average price target for LUNG is $12, which is 83.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 83.2% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Scores
| Altman Z-Score | -1.5 |
| Piotroski F-Score | 4 |